Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glycolytic activity in breast cancer using 18F-FDG PET/CT as prognostic predictor: A molecular phenotype approach.

Revista espanola de medicina nuclear e imagen molecular - 1 Jan 2000

Garcia Vicente A M, Soriano Castrejón A, Amo-Salas M, Lopez Fidalgo J F, Muñoz Sanchez M M, Alvarez Cabellos R, Espinosa Aunion R, Muñoz Madero V

Abstract excerpt

AIM: To explore the relationship between basal (18)F-FDG uptake in breast tumors and survival in patients with breast cancer (BC) using a molecular phenotype approach. MATERIAL AND METHODS: This prospective and multicentre study included 193 women diagnosed with BC. All patients underwent an (18)F-FDG PET/CT prior to treatment. Maximum standardized uptake value (SUVmax) in tumor (T), lymph nodes (N), and the N/T...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Fluorodeoxyglucose F18

Share to Kaplan-Meier Estimate

Share to Multimodal Imaging

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 26522003
DOI: 10.1016/j.remn.2015.08.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glycolytic activity in breast cancer using 18F-FDG PET/CT as prognostic predictor: A molecular phenotype approach.PMID 26522003Read ↗

Basal (18)F-FDG PET/CT as a predictive biomarker of tumor response for neoadjuvant therapy in breast cancer.Semantic proximity Read ↗

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.Semantic proximity Read ↗

Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation.Semantic proximity Read ↗

Breast Cancer Blood Flow and Metabolism on Dual-Acquisition 18F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response.Semantic proximity Read ↗

Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.Semantic proximity Read ↗

Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy.Semantic proximity Read ↗

MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes.Semantic proximity Read ↗

Relationship Among Glycolytic Phenotype, Grade, and Histological Subtype in Ovarian CarcinomaSemantic proximity Read ↗

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status.Semantic proximity Read ↗

Association of Androgen Receptor Expression with Glucose Metabolic Features in Triple-Negative Breast CancerSemantic proximity Read ↗

18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology.Semantic proximity Read ↗

The FAP-FDG Integration Score (FFIS): Development and prognostic validation of a dual-tracer PET phenotype for solid tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.